An independent, nonpartisan record of every U.S. tariff and the revenue it generates.

Tariff Tracker pulls live customs and trade data from Treasury, Census, and the Federal Register, presented exactly as the government publishes it; daily, with full historical context back to January 2025.

Updated each business dayOpen data, public sourcesNo advertising, no tracking
Total Tariff Revenue · Jan 2025 – June 2026iCent-accurate cumulative figure from the U.S. Treasury's Monthly Treasury Statement (Table 4, Customs Duties line). Reflects net receipts after refunds and drawbacks.
$337,061,360,303.91
+$5.2B since June 2026 (provisional · all customs receipts)iFrom the Daily Treasury Statement. Bundles Customs Duties with Merchandise Processing Fee and Harbor Maintenance Tax, so this figure is slightly broader than the MTS number above. Updates each business day.
Today's Customs Receipts
$1,027M
▲ +$544M vs prior business day
Month-to-Date Revenue
$5,204M
July 2026
Calendar YTD Revenue
$78,221M
YTD 2026
Tariffed Product LinesiCount of HTS codes carrying an active trade-action surcharge (Section 232, Section 301, executive surcharges, etc.). A 'product line' is one 10-digit HTS code. Placeholder figure pending Yale Budget Lab effective-rate parsing.
8,217
of 29,583 total product lines

Tariff Browser

Search and filter all 29,583 codes of the Harmonized Tariff Schedule. Tariff-action filters (Section 232, Section 301, executive surcharges), country applicability, and rate-range filters require effective-rate data not yet available.

Harmonized Tariff Schedule

29,811 total codes
HTS CodeDescription
2941.90.10.20Tobramycin (INN)
2941.90.10.25Other
2941.90.10.50Other
2941.90.30Aromatic or modified aromatic
2941.90.30.00Aromatic or modified aromatic
2941.90.30.30Vancomycin (INN) and its salts
2941.90.30.90Other
2941.90.50Other
2941.90.50.00Other
2941.90.50.30Clindamycin (INN) and its salts
2941.90.50.90Other
2942.00Other organic compounds:
2942.00.03.00[2,2'-Thiobis(4-(1,1,3,3-tetramethyl-n-butyl)- phenolato)(2,1)]-O,O',S-(1-butanamine), nickel II
2942.00.05.00Drugs
2942.00.10.00Products described in additional U.S. note 3 to section VI
2942.00.35.00Other
2942.00.50.00Other
3001Glands and other organs for organotherapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organotherapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included:
3001.20.00.00Extracts of glands or other organs or of their secretions
3001.90.01Other
3001.90.01.10Liver
3001.90.01.50Other
3001.90.01.65Heparin
3001.90.01.95Other
3002Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified:
3002.12.00Antisera and other blood fractions
3002.12.00.10Human blood plasma
3002.12.00.20Normal human blood sera, whether or not freeze-dried
3002.12.00.30Human immune blood sera
3002.12.00.40Fetal Bovine Serum (FBS)
3002.12.00.90Other
3002.13.00Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale
3002.13.00.10Monoclonal antibodies
3002.13.00.90Other
3002.14.00Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale
3002.14.00.10Containing monoclonal antibodies
3002.14.00.90Other
3002.15.00Immunological products, put up in measured doses or in forms or packings for retail sale
3002.15.00.11Containing monoclonal antibodies
3002.15.00.91Other
3002.41.00.00Vaccines for human medicine
3002.42.00.00Vaccines for veterinary medicine
3002.49.00Other
3002.49.00.10Ricin
3002.49.00.50Other
3002.51.00.00Cell therapy products
3002.59.00.00Other
3002.90Other:
3002.90.10.00Ferments
3002.90.52Other